GLENMARK PHARMACEUTICALS
Back to Cashflow Statement
|
GLENMARK PHARMACEUTICALS Last 5 Year Cash Flow from Financing Activities History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Cash Flow from Financing Activities | ₹-3,906 Cr | ₹-77 Cr | ₹-520 Cr | ₹-442 Cr | ₹-445 Cr |
What is the latest Cash Flow from Financing Activities ratio of GLENMARK PHARMACEUTICALS ?
Year | Cash Flow from Financing Activities |
---|---|
Mar2024 | ₹-3,906 Cr |
Mar2023 | ₹-77 Cr |
Mar2022 | ₹-520 Cr |
Mar2021 | ₹-442 Cr |
Mar2020 | ₹-445 Cr |
How is Cash Flow from Financing Activities of GLENMARK PHARMACEUTICALS Trending?
Years | Cash Flow from Financing Activities | % Change | |
---|---|---|---|
Mar2024 | ₹-3,906 Cr | Negative | |
Mar2023 | ₹-77 Cr | Negative | |
Mar2022 | ₹-520 Cr | Negative | |
Mar2021 | ₹-442 Cr | Negative | |
Mar2020 | ₹-445 Cr | - |
Compare Cash Flow from Financing Activities of peers of GLENMARK PHARMACEUTICALS
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
GLENMARK PHARMACEUTICALS | ₹60,513.6 Cr | -1.8% | 23.9% | 50.5% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹407,551.0 Cr | 0.4% | 1.8% | 4.5% | Stock Analytics | |
DIVIS LABORATORIES | ₹175,704.0 Cr | -1.1% | 0.1% | 45.6% | Stock Analytics | |
CIPLA | ₹123,675.0 Cr | 3.8% | 1.2% | -1.1% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹121,925.0 Cr | 2.2% | 11.7% | 11.7% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹106,626.0 Cr | 1.4% | -3.3% | -7.2% | Stock Analytics |
GLENMARK PHARMACEUTICALS Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
GLENMARK PHARMACEUTICALS | -1.8% |
23.9% |
50.5% |
SENSEX | -0.4% |
-1.6% |
1.3% |
You may also like the below Video Courses